Pharma Report Winter Edition 2026
We are proud to present the Winter 2026 edition of Haavind’s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published since 2016.
In this year’s Winter edition, we are happy to present a summary of some of the most significant cases which occurred in 2025, including within the fields of patent litigation, pharmaceutical advertising and regulatory affairs.
As a leading law firm on healthcare and life science in Norway, our team continuously and closely monitors legal developments relevant to the pharmaceutical sector. If you wish to discuss how your business can meet the legal challenges of this innovative and highly regulated sector, you are always welcome to contact us
The report is authored by Håkon Austdal, which have extensive experience in advising pharmaceutical companies and other healthcare enterprises in all legal areas affecting this highly innovative and extensively regulated sector.